MedPath

Leuprolide Acetate

Leuprolide Acetate Injection Rx only

Approved
Approval ID

bec9077a-3f04-4887-856d-dde2de24584d

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 25, 2023

Manufacturers
FDA

VGYAAN Pharmaceuticals LLC

DUNS: 024755855

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Leuprolide Acetate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72664-611
Application NumberANDA213829
Product Classification
M
Marketing Category
C73584
G
Generic Name
Leuprolide Acetate
Product Specifications
Effective DateSeptember 25, 2023
FDA Product Classification

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Leuprolide Acetate - FDA Drug Approval Details